Cell And Gene Therapy Manufacturing

  1. Validation Of A qPCR Assay For Host Cell DNA Quantitation 6/9/2025

    Here, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of host cell DNA to help meet regulatory requirements.

  2. Genentech, Myeloid's Approaches To mRNA Technologies 1/29/2024

    Experts at a Cell & Gene Live event discussed the use of mRNA technology in cancer immunotherapy, including a brief overview of the different approaches being used to leverage mRNA technology.

  3. Knowledge Culture Basics — Gene Therapy Education Series: Lentiviral Vectors 6/9/2025

    In this session of our ongoing education series on lentiviral vectors, we delve further into principles of lentiviral transduction and challenges in suspension-based lentivirus production.

  4. The Need for Speed: Dr. Peter Marks and Dr. Nicole Verdun Explain Meeting Unmet Need for Pediatric Patients 1/30/2024

    How can sponsor companies accelerate development in pediatric patients for genetic diseases that affect both children and adults, but where gene therapy holds the greatest promise to address unmet needs in pediatric patients?

  5. Advancing Gene Therapy Development With A Multi-Serotype AAV Resin 5/29/2025

    In this webinar, leading CDMO ABL and Thermo Fisher will share data on implementation of the POROS™ CaptureSelect™ AAVX affinity resin into such an AAV purification platform, including its performance in purifying several serotypes.

  6. Perfusion: Hardware Needs 6/16/2025

    In this video, we will discuss cell retention mechanisms, pumps, and intensification challenges in the perfusion process.

  7. Tailoring Purification Solutions To Address Customer Challenges 5/21/2025

    Developing purification products for novel biotherapeutics requires close customer collaboration to ensure the tools do the job. Hear how these partnerships drive targeted innovation.

  8. Driving Down COGS Audience Q&A 8/18/2023

    Expert panelists provide detailed answers to questions submitted in real time by our registrants providing insightful responses regarding analytical challenges to automation, test automation, and more.

  9. Rapid Process Development And Technical Support For AAV Scaleup 12/17/2024

    Accelerate your AAV production journey. Learn how rapid process development and expert support can streamline your path from vial to purified bulk, ensuring scalable and efficient manufacturing.

  10. Market Demand For AAV Vectors 11/13/2023

    Here, Dave Maheu, VP, Head of Process & Analytical Development at Candel Therapeutics and Curran Simpson, Chief Operating Officer at REGENXBIO detail the key factors driving the adeno associated virus manufacturing market.